/
/
/

Novelix Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)71.00
Volume (₹)912.00
High (₹)71.00
Upper Circuit79.21
Low (₹)58.06
Lower Circuit52.81
Prev Close66.01
52W High (₹)92.00
Price64.20
52W Low (₹)49.01

Share Market Cap & Key Ratios Overview

M.Cap (₹)187.93 Cr
Div. Yield (%)0.00
PE Ratio51.77
Debt to Equity0.00
Price to Book1.51
Book Value17.63
EPS (TTM)1.28
Face Value10.00
ROE (%)0.68

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
CPPLUS-ANSE
PREMIERENE-ANSE
AEGISLOG-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
SREEL-TNSE
NOVELIX-XNSE
LTP
1W Low
1W High
Market cap (₹)
2590-17.5 (-0.67%)
2559
2634
3,53,335Cr
3890-61.15 (-1.55%)
3624.65
3947.90
47,150Cr
888.9+26.9 (3.12%)
850
894
40,334Cr
1180.25-0.6 (-0.05%)
1082
1253.90
38,645Cr
335.35-21.6 (-6.05%)
315
356.75
25,810Cr
456+8.1 (1.81%)
435.40
465.55
14,727Cr
60.57-2.14 (-3.41%)
59.72
62.86
9,182Cr
341.7-0.8 (-0.23%)
326.05
353.95
7,800Cr
343-4.7 (-1.35%)
330.20
350.05
4,225Cr
264.2+10.2 (4.02%)
248.40
271.50
607Cr
64.2-6.99 (-9.82%)
58
71
188Cr

Key Highlights of Novelix Pharmaceuticals Ltd Balance Sheet

Novelix Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹9.95Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹9.95Cr, and the reserves and surplus of the company is ₹7.59Cr.

The company has its non-current liabilities with total liabilities of ₹27.16Cr as of 2025-03-31.

The current liabilities are ₹9.67Cr as of 2025-03-31. At the same time, current assets are ₹26.93Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹4.32Lakh and tangible assets of ₹18.57Lakh, provided in the Novelix Pharmaceuticals Ltd financial statements.